This clinical practice guideline is a focused update on management of Clostridioides difficile
infection (CDI) in adults specifically addressing the use of fidaxomicin and bezlotoxumab for …

Severe outbreaks and deaths have been linked to the emergence and global spread of
fluoroquinolone-resistant Clostridioides difficile over the past two decades. At the same time, …

Human gut microbiota are critical to both the development of and recovery from Clostridioides
difficile infection (CDI). Antibiotics are the mainstay of CDI treatment, yet inherently cause …

Antimicrobial resistance to treatments for Clostridioides difficile infection (CDI) poses a significant
threat to global health. C. difficile is widely thought to be susceptible to oral vancomycin…

Importance RecurrentClostridioides difficileinfection (CDI) is a debilitating disease leading
to poor health-related quality of life (HRQOL), loss of productivity, anxiety, and depression. …

Agents in development for the prevention or treatment of Clostridioides difficile infection can
be split into three broad categories: antibiotics, microbiome restoration, and vaccines. Given …

Background Stool toxin concentrations may impact Clostridioides difficile infection (CDI)
severity and outcomes. We correlated fecal C difficile toxin concentrations, measured by an …

Background Clinical studies have demonstrated inferior cure rates when metronidazole (MTZ)
is used to treat Clostridioides difficile infection (CDI). We hypothesized that a newly …

With the approval and development of narrow-spectrum antibiotics for the treatment of
Clostridioides difficile infection (CDI), the primary endpoint for treatment success of CDI antibiotic …

Background This study was the first human validation of the gram-positive bacterial DNA
polymerase IIIC target in patients with Clostridioides difficile infection. The primary objectives …